Advancements in Microfluidic Cassette-Based iMiDEV™ Technology for Production of L-[11C]Methionine and [11C]Choline

Author:

Mallapura Hemantha1ORCID,Tanguy Laurent2,Mahfuz Samin1,Bylund Lovisa3,Långström Bengt4,Halldin Christer1,Nag Sangram1ORCID

Affiliation:

1. Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, SE-17176 Stockholm, Sweden

2. Business Unit Nuclear Medicine, PMB-Alcen, Route des Michels CD56, F-13790 Peynier, France

3. Department of Radiopharmacy, Karolinska University Hospital, SE-17176 Stockholm, Sweden

4. Department of Medicinal Chemistry, Uppsala University, SE-75123 Uppsala, Sweden

Abstract

Microfluidic technology is a highly efficient technique used in positron emission tomography (PET) radiochemical synthesis. This approach enables the precise control of reactant flows and reaction conditions, leading to improved yields and reduced synthesis time. The synthesis of two radiotracers, L-[11C]methionine and [11C]choline, was performed, using a microfluidic cassette and an iMiDEVTM module by employing a dose-on-demand approach for the synthesis process. We focused on optimizing the precursor amounts and radiosynthesis on the microfluidic cassette. L-[11C]methionine and [11C]choline were synthesized using a microreactor filled with a suitable resin for the radiochemical reaction. Trapping of the [11C]methyl iodide, its reaction, and solid-phase extraction purification were performed on a microreactor, achieving radiochemical yields of >80% for L-[11C]methionine and >60% for [11C]choline (n = 3). The total synthesis time for both the radiotracers was approximately 20 min. All quality control tests complied with the European Pharmacopeia standards. The dose-on-demand model allows for real-time adaptation to patient schedules, making it suitable for preclinical and clinical settings. Precursor optimization enhanced the cost efficiency without compromising the yield. The importance of dose-on-demand synthesis and optimized precursor utilization to produce L-[11C]methionine and [11C]choline was emphasized in this study. The results demonstrated the feasibility of dose-on-demand adaptations for clinical applications with reduced precursor quantities and high radiochemical yields.

Publisher

MDPI AG

Reference30 articles.

1. Basu, S., and Alavi, A. (2008). Unparalleled contribution of 18F-FDG PET to medicine over 3 decades. J. Nucl. Med., 49.

2. FDG PET Hybrid Imaging;Becker;Recent Results Cancer Res.,2020

3. Targeting of activated fibroblasts for imaging and therapy;Lindner;EJNMMI Radiopharm. Chem.,2019

4. New Developments in Peptide Receptor Radionuclide Therapy;Nicolas;J. Nucl. Med.,2019

5. The application of positron emission tomography (PET) imaging in CNS drug development;Suridjan;Brain Imaging Behav.,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3